Learn more
Log in
1 follower
Dyve is a clinical-stage biotech company with its lead asset, DYV700, currently completing a 20-center, 100-patient, Phase 2 clinical study for the treatment of acute gout.
Industries
Headquarters
Stage
Employees
Links
3 members
2 members
Landmark Bio
Black Diamond Therapeutics
VitroLabs
Thermo Fisher Scientific
125 followers
Genentech
134 followers
Discover companies